Modus Advisors’s Gilead Sciences GILD Stock Holding History
Bought
  Maintained
  Sold
  | Quarter | Market Value | Status | Shares | 
        
          
          
            Change in  Stake  | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
| 
        
          
      
        2025
         Q2  | $1.24M | Buy | 
         | 
    |||||
| 
        
          
      
        2025
         Q1  | $1.24M | Buy | 
         | 
    |||||
| 
        
          
      
        2024
         Q4  | $1.01M | Buy | 
         | 
    |||||
| 
        
          
      
        2024
         Q3  | $879K | Buy | 
         | 
    |||||
| 
        
          
      
        2024
         Q2  | $673K | Buy | 
         | 
    |||||
| 
        
          
      
        2024
         Q1  | $648K | Buy | 
         | 
    |||||
| 
        
          
      
        2023
         Q4  | $639K | Buy | 
         | 
    |||||
| 
        
          
      
        2023
         Q3  | $467K | Buy | 
         | 
    |||||
| 
        
          
      
        2023
         Q2  | $435K | Buy | 
         | 
    |||||
| 
        
          
      
        2023
         Q1  | $428K | Buy | 
         | 
    |||||
| 
        
          
      
        2022
         Q4  | $437K | Buy | 
         | 
    |||||
| 
        
          
      
        2022
         Q3  | $249K | Buy | 
         | 
    |||||
| 
        
          
      
        2022
         Q2  | $248K | Buy | 
         | 
    |||||
| 
        
          
      
        2022
         Q1  | $227K | Buy | 
         | 
    |||||
| 
        
          
      
        2021
         Q4  | $220K | Buy | 
         | 
    |||||
| 
        
          
      
        2021
         Q3  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2021
         Q2  | $112K | Buy | 
         | 
    |||||
| 
        
          
      
        2020
         Q3  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2020
         Q2  | $38K | Buy | 
         |